AIM-MET: AI-Guided Microbiome-Targeted Nutrition for Glycemic Improvement in Type 2 Diabetes
Clinical trial NCT07622628 · RECRUITING
Trial details
- NCT number
- NCT07622628
- Sponsor
- ENBIOSIS BIOTECHNOLOGIES
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-03-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.